Eakin Respiratory

27/02/2026

Just published ✍️
➡️ "AMSORB® Plus: Beyond Safety – Driving Clinical and Economic Value"

CO₂ absorbents are often viewed as low-cost background consumables in anaesthesia and ICU ventilation.

From a health economics perspective, however, their impact reaches far beyond unit price.

With millions of surgical procedures performed globally each year, even small per-case efficiencies can translate into meaningful system-level savings — particularly in high-throughput theatres and ICUs managing prolonged ventilation.

Our latest blog by Ozge Harman, Health Economist at Eakin Healthcare, explores how AMSORB® Plus demonstrates value across the full care pathway.💡

Read the full article: https://www.eakinrespiratory.com/blogs/amsorb-plus-beyond-safety/

26/02/2026

Are you ready for a career in a Great Place to Work®?
We're looking for great people to join our team in Coleraine! 💼

Current Opportunities:
➡️ Cleaner - Part Time, Permanent
Apply here: https://eakinhealthcare.bamboohr.com/careers/124

➡️ Production Operator - Full Time, 12 Months Fixed Term
Apply here: https://eakinhealthcare.bamboohr.com/careers/137

Know someone perfect for these roles? Tag them below!

25/02/2026

The AMSORB® Plus G-CAN® comes pre-filled and is specifically engineered for seamless compatibility with GE anaesthesia delivery systems, making installation quick and hassle free.

💡 Take a look at this short video to see how easy it is to install the G-CAN®: https://www.youtube.com/watch?v=HeuX3MIJjbQ

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

23/02/2026

Looking for a safer CO2 absorbent for anaesthesia care? Discover AMSORB® Plus.

🛡️ Safer
Incapable of anaesthetic degradation and does not produce harmful by-products such as formaldehyde, carbon monoxide and compound A.

🙂 Easier to Use
Exhibits a permanent colour-change from white to violet when exhausted, helping to monitor its usage status efficiently and improving confidence in clinical decisions.

💰️ Cost-effective
Low-flow anaesthesia delivery reduces the consumption of anaesthetic agents and lowers your overall cost of ownership.

Learn more: https://www.eakinrespiratory.com/product/amsorb-plus-anaethesia-carbon-dioxide-absorbent/

AMSORB® Plus absorbs carbon dioxide from cellular respiration during anaesthesia.

19/02/2026

Thank you to everyone who attended today's NeoFlow® webinar - Management and outcomes of periviable infants born at 22-23 weeks of gestation: Experience based medicine in Japan.

We were delighted to welcome Dr Fumihiko Namba, who delivered an incredibly insightful and thought-provoking presentation. Thank you, Dr Fumi, for sharing your expertise and experience.

We also want to acknowledge the technical issues experienced by many of you that meant you were unable to join - we sincerely apologise for the inconvenience. If you were affected or would like to revisit the session, the full webinar recording is available here: https://www.eakinrespiratory.com/webinar/management-and-outcomes-of-periviable-infants/

Thank you again for your continued support and engagement 🐨💜

Dr. Fumihiko Namba shared an insightful look at Japan's approach to caring for periviable infants born at 22–23 weeks, discussing global survival trends, Japan’s management strategies and real case examples.

18/02/2026

2️⃣4️⃣ hours to go!

We hope you can join us tomorrow at 9am GMT for the next instalment in our NeoFlow® webinar series, with guest speaker Dr Fumihiko Namba.

Dr Namba will deliver an insightful session exploring Japan's approach to care for periviable infants born at 22-23 weeks of gestation; and feature learnings on how Japanese NICUs have achieved some of the highest survival rates globally for infants born at the limits of viability.

With real case examples and the chance to ask your questions live, this session is ideal for neonatal professionals seeking practical, experience-based insights.💡

Register for free at the link below. We hope to see you there!
3e534509-7ca3-4b6b-ac80-cf5dedf1c279@9f796429-94ba-42c5-a1dc-3d284239d26e" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/3e534509-7ca3-4b6b-ac80-cf5dedf1c279@9f796429-94ba-42c5-a1dc-3d284239d26e

16/02/2026

Last week, we were proud to take part in two international events, connecting with healthcare professionals, partners and industry leaders from around the world. 🌍️

From to , it was a fantastic opportunity to strengthen relationships, exchange ideas and present respiratory solutions that support better patient outcomes every day.

A big thank you to everyone who visited our team and connected with Stephen, Ralf and Roy. Special thanks to Invest NI for facilitating such an impressive showcase of innovative Northern Irish companies at the World Health Expo!

13/02/2026

This Valentine's Day we're turning up the heat❤️‍🔥... clinically, of course.

The AquaVENT® Heater Humidifier delivers heated, humidified gases to patients requiring respiratory support via mechanical ventilation, tracheal tube or face mask - which can help to improve patient comfort and therapy tolerance.

Because when it comes to respiratory care, the right temperature makes all the difference❤️

12/02/2026

The countdown is on - just one week to go!⏰️

We hope you can join us for our upcoming NeoFlow® webinar - Management and outcomes of periviable infants born at 22-23 weeks of gestation: Experience based medicine in Japan.

In this expert-led and educational session, Dr Fumihiko Namba will explore Japan's approach to caring for periviable infants born at 22-23 weeks of gestation; and feature learnings on how Japanese NICUs have achieved some of the highest survival rates globally for infants born at the limits of viability.

🔎 What to expect:
• Real-world case examples.
• Practical, experience-based insights.
• Live Q&A with Dr Namba.

👉️ Register for free: 3e534509-7ca3-4b6b-ac80-cf5dedf1c279@9f796429-94ba-42c5-a1dc-3d284239d26e" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/3e534509-7ca3-4b6b-ac80-cf5dedf1c279@9f796429-94ba-42c5-a1dc-3d284239d26e

11/02/2026

Hallo Bremen!👋

Ralf and Roy are at the Symposium Intensivmedizin + Intensivpflege for the next 3 days, talking all things AquaVENT®.

Visit us at stand 4R02 and discover our acute respiratory care range, designed to support you in delivering the best and safest care for your patients in the acute setting, all from one trusted supplier.

We're looking forward to great conversations and connecting with many of you over the coming days!

06/02/2026

The AquaVENT® FD140i dual therapy flow driver enables a safe, seamless transition between and therapy for neonatal, paediatric and adult patients.

Featuring single unit incremental controls for flow and oxygen, you can confidently ensure the accurate delivery of therapy, while optimising patient comfort and care👩‍⚕️.

▶️💡 Watch the video to learn more:

The AquaVENT® FD140i dual gas flow driver delivers safe and effective High Flow Oxygen Therapy and CPAP therapies for Neonatal, Paediatric and Adult patients.

05/02/2026

📢2 weeks to go. 2 minutes to register.
Don't miss the next instalment in our free NeoFlow® webinar series.

Join Dr. Fumihiko Namba, a neonatal intensive care physician working in one of the largest NICUs in Japan - and learn how Japanese NICUs have achieved some of the highest survival rates globally for periviable infants born at 22-23 weeks of gestation.

With real case examples and the chance to ask your questions live, this session is ideal for neonatal professionals seeking practical, experience-based insights.💬

👉️ Be part of the conversation-register today:
3e534509-7ca3-4b6b-ac80-cf5dedf1c279@9f796429-94ba-42c5-a1dc-3d284239d26e" rel="ugc" target="_blank">https://events.teams.microsoft.com/event/3e534509-7ca3-4b6b-ac80-cf5dedf1c279@9f796429-94ba-42c5-a1dc-3d284239d26e